Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: Influence of treatment on antibody titres to human α6 integrin

Clinical and Experimental Immunology

Volumn 129, Issue 3, 2002, Pages 533-540

  Sami, N ^a,b   Bhol, K C ^a,b   Ahmed, A R ^a,b,c  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Human alpha 6 integrin antibody titres; Immunoblot assay; Intravenous immunoglobulin therapy; Oral pemphigoid

Indexed keywords

ALPHA6 INTEGRIN; AZATHIOPRINE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; PROTEIN ANTIBODY; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; IMMUNOTHERAPY; LONG TERM CARE; MALE; MONOTHERAPY; MOUTH DISEASE; PEMPHIGOID; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SEROLOGY; STATISTICAL SIGNIFICANCE; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ADULT; ANTIBODY SPECIFICITY; ANTIGENS, CD; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULINS, INTRAVENOUS; INTEGRIN ALPHA6; MALE; MIDDLE AGED; MOUTH; PEMPHIGOID, BULLOUS; TREATMENT OUTCOME;

EID: 0036038046     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01942.x     Document Type: Article

References (39)

1. Oral pemphigoid. Subset of cicatricial pemphigoid?
2. Cicatricial pemphigoid
3. Cicatricial pemphigoid. Direct and indirect immunofluorescence studies
4. Differentiating anti-lamina lucida and anti-sub lamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin
5. Update on mucous membrane pemphigoid: A heterogeneous immune-mediated subepithelial entity
6. A structure and function of hemidesmosome: More than simple adhesion complexes
7. Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosome
8. Changes in the expression of integrins and basement membrane proteins in benign mucous membrane pemphigoid
9. Bovine gingival lysate, a novel substrate for rapid diagnosis of autoimmune vesiculobullous diseases. A preliminary observation
10. Autoantibodies to human alpha 6 integrin in patients with oral pemphigoid
11. In vitro organ culture model for mucous membrane pemphigoid
12. Mucous membrane pemphigoid
13. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases
14. Open preliminary trial of clobetasol propionate ointment in adhesive pastefor treatement of chronic oral vesiculoerosive diseases
15. Desquamative gingivitis. Clinical, histopathologic, immunopathologic, and therapeutic observations
16. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone
17. Azathioprine in the treatment of mucocutaneous pemphigoid
18. Intravneious immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid
19. Immunosuppressive agents for use in dermatology
20. Update on systemic glucocorticoids in dermatology
21. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: Effects of disease progression in patient nonresponsive to dapsone therapy
22. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study
23. Intravenous immunoglobulins the therapy of autoimmune and systemic inflammatory disorders
24. High-dose intravenous immunoglobulins. An approach to treat severe immune-mediated and autoimmune diseases of the skin
25. Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment
26. Ocular cicatricial pemphigoid antigen. Partial sequence and biochemical characterization
27. Improved ELISA for determination of anti-diptheria and/or anti-tetanus antitoxin antibody in sera
28. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1
29. Bullous pemphigoid. The latest in the diagnosis, prognosis, and therapy
30. The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognized predominantly epitopes within the large cytoplasmic domain of human beta4
31. Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains
32. 97 kDa linear IgA bullous dermatosis (LAD) antigen localizes to the lamina lucida of the epidermal basement membrane
33. Mechanisms of action of intravenous immunoglobulin in immune-mediated diseases
34. Alpha 6 integrins are required for Langerhans cell migration from the epidermis
35. Effect of intravenous gammaglobulin on organ specific antibodies and lymphocyte subsets
36. A study of 20 SLE patients treated with intravenous immunoglobulin-clinical and serologic response
37. Influence of intravenous immunoglobulin therapy on serum levels of anti-B4 antibodies in ocular cicatricial pemphigoid